In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine kinase-dependent mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1744-1750

  Sauro, Marie Donabella ^a   Sudakow, Robert ^a   Burns, Shannon ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; LOSARTAN; PROTEIN TYROSINE KINASE; TYRPHOSTIN 25; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; ENZYME ACTIVATION; HYPERTENSION; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PROTEIN-TYROSINE KINASES; RATS;

EID: 0030434460     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. AZUMA, H., NIIMI, Y. AND HAMASAKI, H.: Prevention of intimai thickening after endothelial removal by a non-peptide angiotensin II receptor antagonist, losartan. Br. J. Pharmacol. 10: 665-671, 1992.
2. BERK, B. C., ALEXANDER, R. W., BROCK, T. A., GIMBRONE, M. A. AND WEBB, R. C.: Vasoconstriction: A new activity for PDGF. Science (Wash. DC) 232: 87-90, 1986.
3. BERRIDGE, M. J.: Inositol trisphosphate and calcium signaling. Nature (Lond.) 361: 315-325, 1993.
4. BILDER, G. E., KASIEWSKI, C. J., WALEZAK, E. M. AND PERRONE, M. H.: PDGF receptor protein tyrosine kinase activity in carotid artery is enhanced by injury and inhibited in vivo by tyrphostin. Drug Dev. Res. 29:158-166, 1993.
5. BILDER, G. E., KRAWIEC, J. A., MCVETY, D., GAVIT, A., GILON, C., LYALL, R., ZILBERSTEIN, A., LEVITZKI, A., PERRONE, M. H. AND SCHREIBER, A. B.: Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am. J. Physiol. 260: C721-C730, 1991.
6. BOBIK, A., GRINPUKEL, S., LITTLE, P. J., GROOMS, A. AND JACKMAN, G.: Angiotensin II and norepinephrine increase PDGF BB receptor and potentiate PDGF BB-stimulated DNA synthesis in vascular smooth muscle. Biochem. Biophys. Res. Commun. 166: 580-588, 1990.
7. BODART, V., ONG, H. AND DELEAN, A.: A role for protein tyrosine kinases in the steroidogenic pathway of angiotensin II in bovine zona glomerulosa cells (Abstract). Can. J. Physiol. Pharmacol. 72: 555, 1994.
8. BUNAG, R. D.: Validation in awake rats of a tail cuff method for mean systolic blood pressure. J. Appl. Physiol. 34: 279-282, 1973.
9. CAMPBELL-BOSWELL, M. AND ROBERTSON, A. L.: Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Pathol. 35: 265-276, 1981.
10. CAUSSADE, F., VIRONE-ODDOS, A., DELCHAMBRE, C., CAZES, M., VERSIGNY, A. AND CLOAREC, A.: In vitro pharmacological characterization of UP-269-6, a novel non-peptide angiotensin II receptor antagonist. Fund. Clin. Pharmacol. 9: 119-128, 1995.
11. DISALVO, J., STEASLOFF, A., SEMENDOUK, L., SATOH, S., KOLQUIST, K. AND PFITZER, G.: Tyrosine kinase inhibition suppresses agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190: 968-974, 1993.
12. DONALDSON, H. H.: The Rat: Data and Reference Tables, p. 198, Philadelphia Press, Philadelphia, PA, 1979.
13. DUFF, J. L., BERK, B. C. AND CORSON, M. A.: Angiotensin II stimulates pp44 and pp42 MAP kinases in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 188: 257-264, 1992.
14. FLEMING, W. W., WESTFALL, D. P., DELALANDE, I. S. AND JELLETT, L. B.: Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181: 339-345, 1972.
15. FORCE, I., KYRIAKIS, J. A. AND BONVENTRE, J. V.: Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J. Biol. Chem. 266: 6650-6656, 1991.
16. GAZIT, A., YAISH, P., GILON, C. AND LEVITZKI, A.: Tyrphostins. I. Synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32: 2344-2352, 1989.
17. GEISTERFER, A. A. T., PEACH, M. J. AND OWENS, G. K.: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756, 1988.
18. GIASSON, E. AND MELOCHE, S.: Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J. Biol. Chem. 270: 5225-5231, 1995.
19. HOLLENBERG, M.: Tyrosine kinase pathway and the regulation of smooth muscle contractility. Trends Pharmacol. Sci. 15:108-114, 1994.
20. HUCKLE, W. R., PROKOP, C. A., DY, R. C., HERMAN, B. AND EARP, S.: Angiotensin II stimulates protein tyrosine phosphorylation in a calcium-dependent manner. Mol. Cell. Biol. 10: 6290-6298, 1990.
21. KAMM, K. E. AND STULL, J. T.: The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol. Toxicol. 25: 593-620, 1985.
22. LANIYONU, A. A., SAIFEDDINE, M., YANG, S. G. AND HOLLENBERG, M. D.: Tyrosine kinase inhibitors and the contractile action of G-protein-linked vascular agonists. Can. J. Physiol. Pharmacol. 72: 1075-1085, 1994.
23. LEVITZKI, A.: Tyrphostins: Tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J. 6: 3275-3282, 1992.
24. LEVITZKI, A. AND GAZIT, A.: Tyrosine kinase inhibition: An approach to drug development. Science (Wash. DC) 267: 1782-1788, 1995.
25. LINSEMAN, D. A., BENJAMIN, C. W. AND JONES, D. A.: Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J. Biol. Chem. 270:12563-12568, 1995.
26. MARRERO, M. B., PAXTON, W. G., DUFF, J. L., BERK, B. C. AND BERSTEIN, K. E.: Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-1 in vascular smooth muscle cells. J. Biol. Chem. 269: 10935-10939, 1994.
27. MERKEL, L. A., RIVERA, L. M., COLUSI, D. J. AND PERRONE, M. H.: Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with tyrosine kinase inhibitor RG50864. Biochem. Biophys. Res. Commun. 192: 1319-1326, 1993.
28. MOLLOY, C. J., TAYLOR, D. S. AND WEBER, H.: Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268: 7338-7345, 1993.
29. MORGAN, K. G., DEFEO, T. T., WENC, K. AND WEINSTEIN, R.: Alterations of excitation-contraction coupling by platelet-derived growth factor in enzymatically isolated cultured vascular smooth muscle cells. Pfluegers Arch. 405: 77-79, 1985.
30. MORISHITA, R., HIGAKI, J., MIYAZAKI, M. AND OGIHARA, T.: Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension Suppl. II 19: II62-II67, 1992.
31. OWENS, G. K.: Control of hypertrophic versus hyperplastic growth of vascular smooth muscle. Am. J. Physiol. 267: H1755-H1765, 1989.
32. PADEH, S., LEVITZKI, A., GAZIT, A., MILLS, G. B. AND POIFMAN, C. M.: Activation of phospholipase C in human B-cells is dependent on tyrosine phosphorylation. J. Clin. Invest. 87:1114-1118, 1991.
33. PEACH, M. J.: Renin-angiotensin system: Biochemistry and mechanisms of action. Physiol. Rev. 57: 313-370, 1977.
34. POLTE, T. R., NAFTILAN, A. AND HANKS, S. K.: Focal adhesion kinase is abundant in developing vessels and elevation of its phosphotyrosine content in VSMCs is a rapid response to angiotensin II. J. Cell. Biochem. 55: 106-119, 1994.
35. POWELL, J. S., CLOZEL, J. P., MULLER, R. K. M., KUHN, F., HEFTI, F., HOSANG, M. AND BAUMGARTNER, H. R.: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular surgery. Science (Wash. DC) 24: 186-188, 1989.
36. RASMUSSEN, H., TAKUWA, Y. AND PARK, S.: Protein kinase C in the regulation of smooth muscle contraction. FASEB J. 1: 177-185, 1987.
37. ROMAN, C., MILLS, G. B., CHIN, K., GAZIT, A., GILON, C. AND LEVITZKI, A.: Tyrosine phosphorylation is an essential event in the stimulation of B lymphocytes in Staphylococcus aureus. J. Immunol. 146: 2965-2971, 1991.
38. SACHINIDIS, A., Ko, Y., GRAACH, G. K. H., WEICZOREK, A. J. AND VETTER, H.: Action of metoprolol, enalapril, diltiazem, verapamil and nifedipine on cell growth of vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 19: S60-S62, 1992.
39. SADISHIMA, J., QIU, Z., MORGAN, J. P. AND IZUMO, S.: Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and a 90 kD S6 kinase in cardiac myocytes. Circ. Res. 76: 1-15, 1995.
40. SAIFEDDINE, M., LANIYONU, A., YANG, S. AND HOLLENBERG, M. D.: Tyrosine kinase inhibition and the contractile response of angiotensin II in vascular tissue. Pharmacol. Commun. 1:177-184, 1992.
41. SAURO, M. D. AND FITZPATRICK, D. F.: Decreased sensitivity of spontaneously hypertensive rat aortic smooth muscle to vasorelaxation by atriopeptin III. Biochem. Biophys. Res. Commun. 146: 80-86, 1987.
42. SAURO, M. D., HILKER, V. AND MALLOY, L. G.: The role of protein tyrosine kinases (PTKs) in vascular smooth muscle (VSM) function (Abstract). Can. J. Physiol. Pharmacol. 72:162, 1994.
43. SAURO, M. D. AND THOMAS, B.: Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). J. Pharmacol. Exp. Ther. 267:1119-1125, 1993a.
44. SAURO, M. D. AND THOMAS, B.: Decreased sensitivity of vascular smooth muscle from the spontaneously hypertensive rat to vasorelaxation by tyrphostin, a selective inhibitor of protein tyrosine kinases. Life Sci. 53: 371-376, 1993b.
45. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations with Computer Programs, Springer Verlag, New York, 1987.
46. TSUDA, T., KAWAHARA, Y., SHII, K., KOIDE, M., ISHIDA, Y. AND YOKOYAMA, M.: Vasocontriction-induced protein tyrosine kinase phosphorylation in cultured VSMCs. FEBS Lett. 285: 44-48, 1991.
47. TURNER, C. E., PIETRAS, K M., TAYLOR, D. S. AND MOLLOY, C. J.: Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J. Cell Sci. 108: 333-342, 1995.
48. WIJETUNGE, C., AALKJAER, C., SCHACHTER, M. AND HUGHS, A. D.: Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623, 1992.
49. YANG, S. G., SAIFEDDINE, M. AND HOLLENBERG, M. D.: Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can. J. Physiol. Pharmacol. 70: 85-93, 1992.
50. YANG, S. G., SAIFEDDINE, M., LANIYONU, A. AND HOLLENBERG, M.: Distinct signal transduction pathways for angiotensin II in guinea pig gastric smooth muscle. J. Pharmacol. Exp. Ther. 264: 958-966, 1993.